You look at the numbers that just came out for continuing operations, plus the fact they expect to grow revs q/q (not y/y) by 12 percent. Do that every quarter and it's a 58 percent annual gain. Why not assume that figure as we have not yet been provided with 2009 numbers.
So this company is still growing near 60 percent, hasn't recognized a dime from the HPV acquisition and is still trading at shockingly low multiples before or after convertible offerings dilution - but that money raised will likely be turned into cash flow far above the negotiated interest rate. So it's fair to take non-gaap earnings of .67 and assume .77, .88 and 1.00 earnings over the next 3 quarters, plus the recent one announced today.
3.32 earnings x 10 Forward PE, now how about 20 forward PE - so where does that leave us? How about a current 15x PE? Seems very conservative right? But do you know where that would take us?
Thanks for the discussion on PIPEs. Hard to make any significant buy here when CMED keeps going lower and lower. Even a quick 50% move won't be much help to many, as few are willing to risk buying a significant position in this market.
jjjinglehim--Please give me a couple paragraphs to educate me about PIPEs, why they drag a stock pps down, how this is in their interest, and most importantly, what factors cause this Chinese water torture to end.